Biogen Acquires Remedy Pharmaceuticals’ Late-Stage Drug CIRARA™ Remedy Pharmaceuticals
PharmiWeb Solutions | May 18, 2017
Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to people affected by central nervous system diseases and injuries, today announced that Biogen (NASDAQ:BIIB) completed an asset purchase of its Phase 3 candidate.